Drug maker Lupin on Wednesday said it has launched the generic version of Oracea capsules in the US market. The company said it has launched the medication, indicated for the treatment of ...

approval for its Abbreviated New Drug Application (ANDA). This was filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company, for colchicine capsules, 0.6 mg. It ...

scientists have created nanosized capsules that could be used to deliver drugs and messenger RNA (mRNA). mRNA is a molecule that instructs cells to produce proteins and has been used in COVID-19 ...

approved first generic version of Oracea (doxycycline capsules, 40 mg), in the United States. Doxycycline capsules, 40 mg is indicated for the treatment of only inflammatory lesions (papules and ...

SpaceX's 30th robotic Dragon cargo ship is back home to Earth. Dragon departed from the International Space Station (ISS) today (April 28) at 1:10 p.m. EDT (1710 GMT), while the two spacecraft ...

The short ceremony, held recently, was the final phase of the events held to officially rebrand the organisation on January 30, 2024, in the company’s car park. The packing of the capsule had ...

At 9:32am, Lupin was quoting Rs 1,621.30, up Rs 16.25, or 1.01 percent, on the BSE. "The company has announced the launch of first generic version of Oracea (doxycycline capsules, 40 mg), in the ...

today announced that the U.S. Food and Drug Administration (FDA) has approved XOLREMDI™ (mavorixafor) capsules for use in patients 12 years of age and older with WHIM syndrome (warts ...

"Global pharma major Lupin Limited (Lupin) today announced the launch of the first generic version of Oracea® (Doxycycline Capsules, 40 mg) in the United States, after having received approval from ...

Yiling Pharmaceutical's Bazi Bushen capsule, as a representative drug of anti-aging innovative TCM widely recognized in the industry, became one of the focuses of the meeting. At the conference ...

CBD capsules from Medterra ... customer reviews whether the company has been subject to a Food and Drug Administration (FDA) warning letter whether the company makes any unsupported health ...